Table 1 The demographics and clinical characteristics of participants between NMOSD group and the healthy control group
Clinical characteristics | Healthy control group | NMOSD group | P-values | ||
|---|---|---|---|---|---|
N = 41 | N = 41 | ||||
Sex, (N,%) | Male | Female | Male | Female | 0.819 |
14(34.15%) | 27(65.85%) | 16(39.02%) | 25(50.98%) | ||
Age, y (mean ± SD) | 41.76 ± 8.932 | 40.88 ± 15.330 | 0.751 | ||
AQP4-IgG + of patients(n,%) | — | 15(36.58%) | — | ||
Optic neuritis(n,%) | — | 6(14.63%) | — | ||
Acute myelitis(n,%) | — | 29(70.74%) | — | ||
Mix attacks(n,%) | — | 6(14.63%) | — | ||
EDSS<4(n,%) | — | 21(51.21%) | — | ||
EDSS ≥ 4(n,%) | — | 20(48.79%) | — | ||
NLR(M, IQR) | 1.65 (1.06, 2.05) | 1.89 (1.52, 3.60) | 0.01 | ||
MLR(M, IQR) | 0.12 (0.08, 0.19) | 0.88 (0.21, 1.57) | <0.001 | ||
PLR(M, IQR) | 76.96 (65.92, 98.56) | 127.22 (100.82, 163.30) | <0.001 | ||